Hospital
Pershing General Hospital
Pershing General Hospital was paid $955K by Medicaid between Jan 2018 and Dec 2024, across 42 billing codes. Its largest line is 99284, emergency room visit (serious) — 49% of everything it billed.
33Billing provider infoPERSHING GENERAL HOSPITAL
LOVELOCK, NV 89419
LOVELOCK, NV 89419
33aNPI1669490603assigned 07/18/2006
33bProvider typeCritical Access Hospital
28Total paid$955K
24GClaims30,375
24DCodes billed42
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Nevada
Rank by total paid#5 of 9
Median peer was paid$955K
This provider vs. median1.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,267 | $74K | |
| 2019 | 3,954 | $57K | |
| 2020 | 3,172 | $47K | |
| 2021 | 4,087 | $60K | |
| 2022 | 5,387 | $91K | |
| 2023 | 4,631 | $78K | |
| 2024incomplete | 4,877 | $547K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 49% | 2,379 | 1,801 | $468K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 31% | 2,160 | 1,777 | $296K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 6.1% | 1,712 | 361 | $59K |
| 80053 | Comprehensive metabolic panel | 3.8% | 3,507 | 2,904 | $36K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 2.3% | 426 | 398 | $22K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.7% | 1,480 | 1,165 | $17K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1.5% | 753 | 166 | $15K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 423 | 389 | $6K |
| 80050 | General health panel | <1% | 147 | 138 | $6K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 212 | 158 | $5K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 393 | 354 | $5K |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | <1% | 217 | 192 | $4K |
30 more codes
| 99285 | Emergency room visit (most serious) | <1% | 34 | $3K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 163 | $2K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 81 | $2K |
| 80061 | Lipid panel | <1% | 329 | $1K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 496 | $1K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 3,674 | $1K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 104 | $1K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 92 | $845.11 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,053 | $831.84 |
| 87088 | <1% | 324 | $667.00 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 303 | $590.13 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,203 | $416.05 |
| 80305 | <1% | 44 | $161.50 | |
| 81001 | <1% | 1,525 | $160.93 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 41 | $153.93 |
| 91322 | <1% | 13 | $119.69 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 5,668 | $103.17 |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 207 | $93.52 |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 131 | $50.19 |
| 85610 | <1% | 33 | $26.90 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 632 | $8.77 |
| 83690 | 0% | 19 | $0.00 | |
| 96375 | Therapeutic injection; each additional sequential IV push | 0% | 13 | $0.00 |
| 84484 | 0% | 35 | $0.00 | |
| 84512 | 0% | 36 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 22 | $0.00 |
| Q2039 | Influenza virus vaccine, not otherwise specified | 0% | 18 | $0.00 |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 198 | $0.00 |
| 87631 | 0% | 63 | $0.00 | |
| 87634 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHIXENBAUGH, CYNTHIA (CEO)
| Provider | Location | Paid |
|---|---|---|
| Pershing General Hospital | Lovelock, NV | $2.19M |
| Pershing General Hospital | Lovelock, NV | $15K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.